AU2001280105A1 - Methof of regulating apoptosis and apoptosis-regulatory polypeptide - Google Patents

Methof of regulating apoptosis and apoptosis-regulatory polypeptide

Info

Publication number
AU2001280105A1
AU2001280105A1 AU2001280105A AU8010501A AU2001280105A1 AU 2001280105 A1 AU2001280105 A1 AU 2001280105A1 AU 2001280105 A AU2001280105 A AU 2001280105A AU 8010501 A AU8010501 A AU 8010501A AU 2001280105 A1 AU2001280105 A1 AU 2001280105A1
Authority
AU
Australia
Prior art keywords
apoptosis
methof
regulating
regulatory polypeptide
regulatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280105A
Inventor
Naoya Fujita
Saori Sato
Takashi Tsuruo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU2001280105A1 publication Critical patent/AU2001280105A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001280105A 2000-08-22 2001-08-22 Methof of regulating apoptosis and apoptosis-regulatory polypeptide Abandoned AU2001280105A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000251529 2000-08-22
JP2000-251529 2000-08-22
PCT/JP2001/007179 WO2002015925A1 (en) 2000-08-22 2001-08-22 Methof of regulating apoptosis and apoptosis-regulatory polypeptide

Publications (1)

Publication Number Publication Date
AU2001280105A1 true AU2001280105A1 (en) 2002-03-04

Family

ID=18740921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280105A Abandoned AU2001280105A1 (en) 2000-08-22 2001-08-22 Methof of regulating apoptosis and apoptosis-regulatory polypeptide

Country Status (3)

Country Link
JP (1) JPWO2002015925A1 (en)
AU (1) AU2001280105A1 (en)
WO (1) WO2002015925A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81634C2 (en) * 2002-07-18 2008-01-25 Хеликс Биофарма Корп. Pharmaceutical compoosition containing urease for inhibiting cancer cell growth
US7959915B2 (en) 2003-03-12 2011-06-14 Tufts University Inhibitors of extracellular Hsp90
AU2005221470B2 (en) * 2003-03-12 2010-05-20 Tufts University Inhibitors of extracellular hsp90
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
US7691838B2 (en) * 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
WO2008032876A1 (en) * 2006-09-15 2008-03-20 Tokai University Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same
EA019156B1 (en) 2008-02-01 2014-01-30 Такеда Фармасьютикал Компани Лимитед Oxim derivatives as hsp90 inhibitors

Also Published As

Publication number Publication date
WO2002015925A1 (en) 2002-02-28
JPWO2002015925A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
AU4505997A (en) Sulfonamides and derivatives thereof that modulate the activity of endothelin
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
AU2002217926A1 (en) Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2003286746A1 (en) Modulators of angiogenesis and tumorigenesis
AU2002329231A1 (en) Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof
AU6143998A (en) Regulators of apoptosis
AU2002320470A1 (en) Modulators of ceramidase and methods of use based thereon
AU2001280105A1 (en) Methof of regulating apoptosis and apoptosis-regulatory polypeptide
AU2002366310A1 (en) Method of inducing apoptosis and compositions therefor
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU2587499A (en) Suppression of alpha-amylase and protease expression using serine/threonine protein kinase
AU1126000A (en) Proliferation and apoptosis related proteins
AU4445701A (en) Multiple human and mouse otoferlin isoforms
AU2001275063A1 (en) Regulators of apoptosis
AU2388800A (en) Stable subtilin and methods of manufacture
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU3289599A (en) Mekk1 proteins and fragments thereof for use in regulating apoptosis
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2003277537A1 (en) REGULATION OF INTERACTION BETWEEN RAPL AND Rap1
AU2211100A (en) Therapeutic applications of flint polypeptides
AU2003297554A1 (en) Modulation of death-associated protein kinase 1 expression
AU2001277750A1 (en) Use of polypeptide
AU2001293780A1 (en) Regulation of human protein phosphatase iic-like enzyme